1 study found for:    24322398 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Valsartan 160 mg + nateglinide 60 mg;   Drug: Valsartan 160 mg + nateglinide placebo;   Drug: Nateglinide 60 mg + valsartan placebo;   Drug: Valsartan placebo + nateglinide placebo

Indicates status has not been verified in more than two years